Australian Broker Call

Produced and copyrighted by at www.fnarena.com

December 24, 2021

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

BKG  BOOKTOPIA GROUP LIMITED

Online media & mobile platforms

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.38

Morgans rates BKG as Add (1) -

Booktopia Group has provided a disappointing pre-Christmas update, with covid impacts, costs and distribution bottlenecks leading to renewed fist half revenue guidance well below Morgans' estimate.

The broker cuts FY22-24 earnings forecasts by -25-41% and lowers its target to $2.78 from $3.72.

The broker nevertheless continues to see longer term upside from increased market share, distribution centre automation and growth in publishing services. Add retained.

Target price is $2.78 Current Price is $1.38 Difference: $1.4
If BKG meets the Morgans target it will return approximately 101% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of 1.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 86.25.

Forecast for FY23:

Morgans forecasts a full year FY23 dividend of 0.10 cents and EPS of 3.90 cents.
At the last closing share price the estimated dividend yield is 0.07%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 35.38.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CGC  COSTA GROUP HOLDINGS LIMITED

Agriculture

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.03

Citi rates CGC as Buy (1) -

Citi incorporates Costa Group's forecast FY22 rental expense and increase in lease liabilities and right-of-use assets from Costa’s new leases for the seven berry and citrus properties previously owned by Vitalharvest.

FY22 forecast earnings thus rise 2% but profit falls -9%, in line with guidance.

Buy and $3.45 target retained.

Target price is $3.45 Current Price is $3.03 Difference: $0.42
If CGC meets the Citi target it will return approximately 14% (excluding dividends, fees and charges).

Current consensus price target is $3.56, suggesting upside of 16.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 7.00 cents and EPS of 14.40 cents.
At the last closing share price the estimated dividend yield is 2.31%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.04.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.6, implying annual growth of -8.8%.

Current consensus DPS estimate is 8.3, implying a prospective dividend yield of 2.7%.

Current consensus EPS estimate suggests the PER is 22.6.

Forecast for FY22:

Citi forecasts a full year FY22 dividend of 7.00 cents and EPS of 14.00 cents.
At the last closing share price the estimated dividend yield is 2.31%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.0, implying annual growth of 25.0%.

Current consensus DPS estimate is 9.4, implying a prospective dividend yield of 3.1%.

Current consensus EPS estimate suggests the PER is 18.1.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

KLL  KALIUM LAKES LIMITED

Mining

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.13

Morgans rates KLL as Add (1) -

Kalium Lakes has reported practical completion of construction activities at Beyondie but flags a slower ramp-up in production as commissioning activities continue and remediation/rectification works on problem areas are planned.

Morgans had already made allowance for production to ramp up slower than the company guided, but now does not expect first revenue until Q3FY22 (from Q2) and pushes full rate production back to Q1FY24 (from Q4FY23).

Delayed production and a slower ramp-up increase the risk of a funding gap but for now Morgans retains an Add (Speculative Buy) rating. Target falls to 25c from 27c.

Target price is $0.25 Current Price is $0.13 Difference: $0.12
If KLL meets the Morgans target it will return approximately 92% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 32.50.

Forecast for FY23:

Morgans forecasts a full year FY23 dividend of 0.00 cents and EPS of 0.00 cents.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PXA  PEXA GROUP LIMITED

More Research Tools In Stock Analysis - click HERE

Overnight Price: $18.35

ADDED

UBS rates PXA as Initiation of coverage with Buy (1) -

UBS has initiated coverage of Pexa Group with a maiden price target of $20.50 alongside a Buy recommendation, arguing this is a globally unique financial infrastructure company.

Having digitised the vast majority of Australian conveyancing transactions, the company is now eyeing offshore expansion. UBS's positive view is premised on success in the UK, which is estimated to boost the FY24 performance by 25% above prospectus forecast.

Target price is $20.50 Current Price is $18.35 Difference: $2.15
If PXA meets the UBS target it will return approximately 12% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY22:

UBS forecasts a full year FY22 EPS of 37.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 49.59.

Forecast for FY23:

UBS forecasts a full year FY23 EPS of 39.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 47.05.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Last Price Broker New Target Prev Target Change
BKG Booktopia Group $1.35 Morgans 2.78 3.72 -25.27%
KLL Kalium Lakes $0.12 Morgans 0.25 0.27 -7.41%
Summaries
BKG Booktopia Group Add - Morgans Overnight Price $1.38
CGC Costa Group Buy - Citi Overnight Price $3.03
KLL Kalium Lakes Add - Morgans Overnight Price $0.13
PXA PEXA Group Initiation of coverage with Buy - UBS Overnight Price $18.35
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

4

Friday 24 December 2021

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.